Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer

Autor: Eline Ruigrok, Rob C.M. Pelger, Maaike H. van der Mark, Emily Ploeg, Gabri van der Pluijm, Ellen C. Zwarthoff, Arjanneke F. van de Merbel, Marianna Kruithof-de Julio, Janneke van Uhm, George N. Thalmann, Laura Appelman, Joost L. Boormans, Chris H. Bangma, Siri Tvingsholm, Geertje van der Horst, Marja Jäätelä

Publikováno v: Molecular Oncology, 14(12), 3121-3134. WILEY
van der Horst, Geertje; van de Merbel, Arjanneke F; Ruigrok, Eline; van der Mark, Maaike H; Ploeg, Emily; Appelman, Laura; Tvingsholm, Siri; Jäätelä, Marja; van Uhm, Janneke; Kruithof-de Julio, Marianna; Thalmann, George N.; Pelger, Rob C M; Bangma, Chris H; Boormans, Joost L; van der Pluijm, Gabri; Zwarthoff, Ellen C (2020). Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer. Molecular oncology, 14(12), pp. 3121-3134. Elsevier 10.1002/1878-0261.12793
Molecular Oncology, 14(12), 3121-3134. John Wiley & Sons Ltd.
Molecular Oncology

Repurposing FDA‐approved, antipsychotic cationic amphiphilic drugs like penfluridol dose‐dependently decreased viability of human bladder cancer cells, significantly reduced tumor progression and metastasis in an orthotopic human bladder cancer x

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7fd1e07e5687764416f6ec6258e2313
http://hdl.handle.net/1887/3184947